Document:

<PAGE>

                                                                   Exhibit 10.35

                               IMMUNEX CORPORATION
                              AMENDED AND RESTATED
                          LEADERSHIP CONTINUITY POLICY
                             AS OF OCTOBER 25, 2001

                  The Company hereby adopts the Immunex Corporation Amended and
Restated Leadership Continuity Policy for the benefit of certain employees of
the Company and its Affiliates, on the terms and conditions hereinafter stated.
All capitalized terms used herein are defined in Section 1 hereof.

                  17.   DEFINITIONS.  As hereinafter used:
                        -----------

                  17.1  "Affiliate" shall have the meaning set forth in Rule
                         ---------
12b-2 under Section 12 of the Exchange Act.

                  17.2  "Beneficial Owner" shall have the meaning set forth in
                         ----------------
Rule 13d-3 under the Exchange Act.

                  17.3  "Board" means the Board of Directors of the Company.
                         -----

                  17.4  "Cause" means (i) the willful and continued failure by
                         -----
the Eligible Employee to substantially perform the Eligible Employee's duties

with the Company (other than any such failure resulting from the Eligible

Employee's incapacity due to physical or mental illness), or (ii) the willful

engaging by the Eligible Employee in conduct which is demonstrably injurious to

the Company, monetarily or otherwise. For purposes of this definition, no act,

or failure to act, on the Eligible Employee's part shall be deemed "willful"

unless done, or omitted to be done, by the Eligible Employee not in good faith

or without reasonable belief that the Eligible Employee's act, or failure to

act, was in the best interest of the Company.

                  17.5  "Change in Control" shall be deemed to have occurred if
                         -----------------

the event set forth in any one of the following paragraphs shall have occurred:

                             (I)   any Person, other than American Home Products

                  Corporation or any of its Affiliates, is or becomes the

                  Beneficial Owner, directly or indirectly, of securities of the

                  Company representing 35% or more of the combined voting power

                  of the Company's

<PAGE>

then outstanding securities, excluding any Person who becomes such a Beneficial

Owner in connection with a transaction described in clause (i) of paragraph (3)
below; or

                        (II)   the following individuals cease for any reason to

constitute a majority of the number of directors then serving: individuals who,

as of the date hereof, constitute the Board and any new director (other than a

director whose initial assumption of office is in connection with an actual or

threatened election contest, including but not limited to a consent

solicitation, relating to the election of directors of the Company) (i) whos

appointment or election by the Board or nomination for election by the Company's

shareholders was approved or recommended by a vote of at least two-thirds (2/3)

of the directors then still in office who either were directors on the date

hereof or whose appointment, election or nomination for election was previously

so approved or recommended or (ii) who is an Investor Director nominated by

American Home Products Corporation or any of its Affiliates; or

                        (III)  there is consummated a merger or consolidation of

the Company or any direct or indirect subsidiary of the Company with any other

corporation, other than (i) a merger or consolidation which would result in the

voting securities of the Company outstanding immediately prior to such merger or

consolidation continuing to represent (either by remaining outstanding or by

being converted into voting securities of the surviving entity or any parent

thereto), at least 60% of the combined voting power of the securities of the

Company or such surviving entity or any parent thereof outstanding immediately

after such merger or consolidation, or (ii) a merger or consolidation effected

to implement a recapitalization of the Company (or similar transaction) in which

no Person (other than American Home Products Corporation and its Affiliates) is

or becomes the Beneficial Owner, directly or indirectly, of securities of the

Company (not including in the securities Beneficially Owned by such Person any

securities acquired directly from the

<PAGE>

                  Company or its Affiliates) representing 35% or more of the

                  combined voting power of the Company's then outstanding

                  securities; or

                        (IV)   the shareholders of the Company approve a plan of

                  complete liquidation or dissolution of the Company or there is

                  consummated an agreement for the sale or disposition by the

                  Company of all or substantially all of the Company's assets,

                  other than a sale or disposition by the Company of all or

                  substantially all of the Company's assets to an entity, at

                  least 60% of the combined voting power of the voting

                  securities of which are owned by shareholders of the Company

                  in substantially the same proportions as their ownership of

                  the Company immediately prior to such sale; or

                        (V)    American Home Products Corporation (together with

                  its Affiliates), is or becomes the Beneficial Owner, directly

                  or indirectly, of securities of the Company (not including in

                  the securities beneficially owned by such Person any

                  securities acquired directly from the Company or its

                  Affiliates) representing 70% or more of the combined voting

                  power of the Company's then outstanding securities.

     Notwithstanding the foregoing, a "Change in Control" shall not be deemed to
have occurred by virtue of the consummation of any transaction or series of
integrated transactions immediately following which the record holders of the
common stock of the Company immediately prior to such transaction or series of
transactions continue to have substantially the same proportionate ownership in
an entity which owns all or substantially all of the assets of the Company
immediately following such transaction or series of transactions.

                  17.6  "Code" means the Internal Revenue Code of 1986, as it
                         ----
may be amended from time to time.

                  17.7  "Company" means Immunex Corporation (collectively
                         -------
with its subsidiaries), or any successors thereto.

                  17.8  "Eligible Employee" means any employee of the Company
                         -----------------
who is a Tier 1, Tier 2 or Tier 3 Employee. An Eligible Employee becomes a

"Severed Employee" once he or she incurs a Severance.
 ----------------

<PAGE>

                  17.9  "Exchange Act" shall mean the Securities Exchange Act of
                         ------------
1934, as amended from time to time.

                  17.10 "Excise Tax" shall mean any excise tax imposed under
                         ----------
section 4999 of the Code.

                  17.11 "Good Reason" in respect of an Eligible Employee means,
                         -----------
the occurrence, on or after the date of a Change in Control and without the

affected Eligible Employee's written consent, of (i) the assignment to the

Eligible Employee of duties in the aggregate that are inconsistent with the

Eligible Employee's level of responsibility immediately prior to the date of the

Change in Control or any diminution in the nature or status of the Eligible

Employee's responsibilities from those in effect immediately prior to the date

of the Change in Control (including, without limitation, in the case of a Tier 1
Employee who was, immediately prior to the Change in Control, an executive

officer of the Company, such employee ceasing to be an executive officer of a

public company); (ii) a reduction by the Company in the Eligible Employee's

annual base salary, annual incentive compensation opportunity, or long term

incentive compensation opportunity (including an adverse change in performance

criteria or a decrease in the target amount of annual or long term incentive

compensation) from that in effect immediately prior to the Change in Control; or

(iii) the relocation of the Eligible Employee's principal place of employment to

a location more than fifty (50) miles from the Eligible Employee's principal

place of employment immediately prior to the date of the Change in Control.

Notwithstanding the preceding sentence, any termination of employment by a Tier

1 Employee, whether voluntary or involuntary, for any reason or no reason, after

the first anniversary of a Change in Control but within sixty (60) days

following such anniversary shall be deemed to constitute a termination for Good

Reason hereunder, provided that, for purposes of this sentence only, in

determining whether a Change in Control has occurred pursuant to Section 1.5(1),

any securities acquired by any Person directly from the Company shall not be

included in the securities beneficially owned by such Person.

                  17.12 "Gross-Up Payment" shall have the meaning set forth in
                         ----------------
Section 2.4 hereof.

                  17.13 "Person" shall have the meaning given in Section 3(a)(9)
                         ------
of the Exchange Act, as modified and used in Sections 13(d) and 14(d) thereof,
except that such term shall not include (i) the Company

<PAGE>

or any of its Affiliates, (ii) a trustee or other fiduciary holding securities

under an employee benefit plan of the Company or any of its subsidiaries, (iii)

an underwriter temporarily holding securities pursuant to an offering of such

securities or (iv) a corporation owned, directly or indirectly, by the

stockholders of the Company in substantially the same proportions as their

ownership of stock of the Company.

                  17.14 "Plan" means the Immunex Corporation Amended and
                         ----
Restated Leadership Continuity Policy, as set forth herein, as it may be amended

from time to time.

                  17.15 "Plan Administrator" means the person or persons

appointed from time to time by the Board which appointment may be revoked at any

time by the Board.

                  17.16 A "Potential Change in Control" shall be deemed to have

occurred if the event set forth in any one of the following paragraphs shall

have occurred:

                        (I)    the Company enters into an agreement, the

                  consummation of which would result in the occurrence of a

                  Change in Control;

                        (II)   the Company or any Person publicly announces an

                  intention to take or to consider taking actions which, if

                  consummated, would constitute a Change in Control;

                        (III)  any Person, other than American Home Products

                  Corporation or any of its Affiliates, becomes the Beneficial

                  Owner, directly or indirectly, of securities of the Company

                  representing 15% or more of either the then outstanding shares

                  of common stock of the Company or the combined voting power of

                  the Company's then outstanding securities; or

                        (IV)   the Board adopts a resolution to the effect that

                  a Potential Change in Control has occurred.

<PAGE>

                  17.17  "Savings Plan" means the Immunex Corporation Profit
                          ------------
Sharing 401(k) Plan and Trust, as it may be amended and restated from time to

time, or any successor thereto.

                  17.18  "Severance" means the termination of an Eligible
                          ---------

Employee's employment with the Company on or within two (2) years following the

date of the Change in Control, (i) by the Company other than for Cause, or (ii)

by the Eligible Employee for Good Reason. An Eligible Employee will not be

considered to have incurred a Severance if his or her employment is discontinued

by reason of the Eligible Employee's death or a physical or mental condition

causing such Eligible Employee's inability to substantially perform his or her

duties with the Company, including, without limitation, such condition entitling

him or her to benefits under any sick pay or disability income policy or program

of the Company.

                  17.19  "Severance Date" means the date on or after the date of
                          --------------

the Change in Control on which an Eligible Employee incurs a Severance.

                  17.20  "Severance Pay" means the payment determined pursuant
                          -------------

to Section 2.1, 2.2 and 2.3 hereof, as applicable.

                  17.21  "Tier 1 Employee" means any executive officer of the
                          ---------------

Company.

                  17.22  "Tier 2 Employee" means any senior vice president or
                          ---------------

vice president of the Company who is not a Tier 1 Employee.

                  17.23  "Tier 3 Employee" means any employee who is a senior
                          ---------------

director or director of the Company or any employee of the Company whose pay

grade level is equivalent to that of a senior director or director, who is not a

Tier 1 or Tier 2 Employee.

                  18.    BENEFITS.
                         --------

                  18.1   Each Tier 1 Employee who incurs a Severance shall be

entitled, subject to Section 2.10, to receive Severance Pay equal to (i) the sum

of his or her annual base salary, his or her target annual incentive

compensation with respect to the year in which the Change in Control occurs, and

the value of the

<PAGE>

contributions or allocations made, as applicable, on his or her behalf to the

Savings Plan with respect to the calendar year immediately preceding the

calendar year of the Change in Control, (ii) multiplied by three (3). For

purposes of this Section, annual base salary shall be determined immediately

prior to the Severance (without regard to any reductions therein which

constitute Good Reason). The Severance Pay due to a Tier 1 Employee in

accordance with this Section shall be paid to such employee no later than

fifteen (15) days immediately following the expiration of the revocation period

if any, applicable to such Severed Employee's release described in Section 2.10.

                  18.2   Each Tier 2 Employee who incurs a Severance shall be

entitled, subject to Section 2.10, to receive Severance Pay equal to (i) the sum

of his or her annual base salary, his or her highest target incentive

compensation with respect to the year in which the Change in Control occurs, and

the value of the contributions or allocations made, as applicable, on his or her

behalf to the Savings Plan with respect to the calendar year immediately

preceding the calendar year of the Change in Control, (ii) multiplied by two

(2). For purposes of this Section, annual base salary shall be determined

immediately prior to the Severance (without regard to any reductions therein

which constitute Good Reason). The Severance Pay due to a Tier 2 Employee in

accordance with this Section shall be paid to such employee no later than

fifteen (15) days immediately following the expiration of the revocation period,

if any, applicable to such Severed Employee's release described in Section 2.10.

                  18.3   Each Tier 3 Employee who incurs a Severance shall be

entitled, subject to Section 2.10, to receive Severance Pay equal to the sum of

his or her annual base salary, his or her highest target incentive compensation

with respect to the year in which the Change in Control occurs, and the value of

the contributions or allocations made, as applicable, on his or her behalf to th

calendar year of the Change in Control. For purposes of this Section, annual

base salary shall be determined immediately prior to the Severance (without

regard to any reductions therein which constitute Good Reason). The Severance

Pay due to a Tier 3 Employee in accordance with this Section shall be paid to

such employee no later than fifteen (15) days immediately following the

expiration of the revocation period, if any, applicable to such Severed

Employee's release described in Section 2.10.

<PAGE>

                  18.4   If any of the payments or benefits received or to be

received by a Tier 1 Employee in connection with the Change in Control or his or

her termination of employment (whether pursuant to the terms of this Plan or any

other plan, arrangement or agreement) (such payments or benefits, excluding the

Gross-Up Payment, being hereinafter referred to as the "Tier 1 Total Payments")

will be subject to the Excise Tax, the Company shall pay to the Tier 1 Employee

an additional amount (the "Gross-Up Payment") such that the net amount retained

by the Eligible Employee, after deduction of any Excise Tax on the Tier 1 Total

Payments, any federal, state and local income and employment taxes and Excise

Tax upon the Gross-Up Payment and after taking into account the phase out of

itemized deductions and personal exemptions attributable to the Gross-Up

Payment, shall be equal to the Tier 1 Total Payments. The amount of the Gross-Up

Payment, if any, shall be determined by the Plan Administrator or any person or

entity designated by the Plan Administrator. The Gross-Up Payment, if any, shall

be paid in a cash lump sum, as soon as practicable following the Severance Date,

but, in any event, not later than twenty (20) business days immediately

following the expiration of the revocation period, if any, applicable to such

Severed Employee's release, described in Section 2.10.

                  18.5   If any of the payments or benefits received or to be

received by a Tier 2 or Tier 3 Employee in connection with the Change in Control

or his or her termination of employment (whether pursuant to the terms of this

Plan or any other plan, arrangement or agreement) (such payments or benefits

being hereinafter referred to as the "Tier 2/3 Total Payments") would be subject

(in whole or part), to the Excise Tax, then, after taking into account any

reduction in the Tier 2/3 Total Payments provided by reason of section 280G of

the Code in such other plan, arrangement or agreement, the Severance Pay shall

be reduced to the extent necessary so that no portion of the Tier 2/3 Total

Payments is subject to the Excise Tax but only if (A) the net amount of such

Tier 2/3 Total Payments, as so reduced (and after subtracting the net amount of

federal, state and local income taxes on such reduced Tier 2 Total Payments) is

greater than or equal to (B) the net amount of such Tier 2/3 Total Payments

without such reduction (but after subtracting the net amount of federal, state

and local income taxes on such Tier 2/3 Total Payments and the amount of Excise

Tax to which the Tier 2 or Tier 3 Employee would be subject in respect of such

unreduced Tier 2/3 Total Payments).

<PAGE>

                  18.6   The Company shall provide each Severed Employee with

individual outplacement services, in a manner consistent with such Severed

Employee's position prior to the Change in Control, for a period of up to twelve

(12) months, commencing on the date such Severed Employee first uses the

outplacement services.

                  18.7   Commencing on the day immediately following a Severed

Employee's Severance Date, until (i) the third anniversary of the Severance Date

for Tier 1 Employees, (ii) the second anniversary of the Severance Date for Tier

2 Employees or (iii) the first anniversary of the Severance Date for Tier 3

Employees, as applicable, the Company shall provide such Severed Employee and

anyone entitled to claim under or through such Severed Employee all (a) benefits

under any group hospitalization, health care plan, dental care plan, life or

other insurance or death benefit plan, or other present or future similar group

employee benefit plan or program of the Company (excluding any benefits provided

under any Company disability program or plan), and (b) other perquisites,

including, without limitation, financial counseling and tax planning services by

AYCO or a company providing comparable equivalent services, to the same extent

as if such Severed Employee had continued to be an employee during such period.

If, during the period in which a Severed Employee is entitled to extended

benefit coverage pursuant to this Section, a Severed Employee obtains employment

which provides substantially similar benefits to any of the benefits described

in (a), coverage under the applicable plans and programs of the Company shall

become secondary to the coverage provided through such employment. The coverage

period for purposes of the group health continuation requirements of section

4980B of the Code shall commence immediately following the end of the period in

which a Severed Employee is entitled to extended benefit coverage pursuant to

this Section.

                  18.8   The Company shall pay to each Eligible Employee all

reasonable legal fees and expenses incurred by such Eligible Employee in

pursuing any claim under the Plan in which such Eligible Employee prevails in

any material respect.

                  18.9   In the event of a claim by an Eligible Employee as to

the amount or timing of any distribution, such Eligible Employee shall present

the reason for his or her claim in writing to the Plan

<PAGE>

Administrator. The Plan Administrator shall, within sixty (60) days after

receipt of such written claim, send a written notification to the Eligible

Employee as to its disposition. In the event the claim is wholly or partially

denied, such written notification shall (i) state the specific reason or reasons

for the denial, (ii) make specific reference to pertinent Plan provisions on

which the denial is based, (iii) provide a description of any additional

material or information necessary for the Eligible Employee to perfect the claim

and an explanation of why such material or information is necessary, and (iv)

set forth the procedure by which the Eligible Employee may appeal the denial of

his or her claim. In the event an Eligible Employee wishes to appeal the denial

of his or her claim, he or she may request a review of such denial by making

application in writing to the Plan Administrator within sixty (60) days after

receipt of such denial. Such Eligible Employee (or his or her duly authorized

legal representative) may, upon written request to the Plan Administrator,

review any documents pertinent to his or her claim, and submit in writing,

issues and comments in support of his or her position. Within sixty (60) days

after receipt of a written appeal (unless special circumstances, such as the

need to hold a hearing, require an extension of time, but in no event more than

one hundred twenty (120) days after such receipt), the Plan Administrator shall

notify the Eligible Employee of the final decision. The final decision shall be

in writing and shall include specific reasons for the decision, written in a

manner calculated to be understood by the claimant, and specific references to

the pertinent Plan provisions on which the decision is based.

                  18.10  No Severed Employee shall be eligible to receive

Severance Pay or other benefits under the Plan unless he or she first executes a

written release substantially in the form attached hereto as Schedule A, (or, if

the Severed Employee is not a United States employee, a similar release which is

in accordance with the applicable laws of the relevant jurisdiction).

                  18.11  The Company shall be entitled to withhold from amounts

to be paid to the Severed Employee hereunder any federal, state or local

withholding or other taxes or charges (or foreign equivalents of such taxes or

charges) which it is from time to time required to withhold.

                  19.    PLAN ADMINISTRATION.
                         -------------------

<PAGE>

                  19.1  The Plan Administrator shall administer the Plan and may

interpret the  Plan, prescribe, amend and rescind rules and regulations under

the Plan and make all other determinations necessary or advisable for the

administration of the Plan, subject to all of the provisions of the Plan,

including, without limitation, Section 2.9 thereof.

                  19.2  The Plan Administrator may delegate any of its duties

hereunder to such person or persons from time to time as it may designate.

                  19.3  The Plan Administrator is empowered, on behalf of the

Plan, to engage accountants, legal counsel and such other personnel as it deems

necessary or advisable to assist it in the performance of its duties under the

Plan. The functions of any such persons engaged by the Plan Administrator shall

be limited to the specified services and duties for which they are engaged, and

such persons shall have no other duties, obligations or responsibilities under

the Plan. Such persons shall exercise no discretionary authority or

discretionary control respecting the management of the Plan. All reasonable

expenses thereof shall be borne by the Company.

                  20.   PLAN MODIFICATION OR TERMINATION.
                        --------------------------------

                  The Plan may be amended or terminated by the Board at any

time; provided, however, that the Plan may not be terminated or amended during

the pendency of, or within six (6) months following, a Potential Change in

Control or within two (2) years following a Change in Control.

                  21.   GENERAL PROVISIONS.
                        ------------------

                  21.1  Except as otherwise provided herein or by law, no right

or interest of any Eligible Employee under the Plan shall be assignable or

transferable, in whole or in part, either directly or by operation of law or

otherwise, including without limitation by execution, levy, garnishment,

attachment, pledge or in any manner; no attempted assignment or transfer thereof

shall be effective; and no right or interest of any Eligible Employee under the

Plan shall be liable for, or subject to, any obligation or liability of such

Eligible Employee.

<PAGE>

When a payment is due under this Plan to a Severed Employee who is unable to

care for his or her affairs, payment may be made directly to his or her legal

guardian or personal representative.

                  21.2  If the Company is obligated by law or by contract to pay

severance pay, a termination indemnity, notice pay, or the like, or if the

Company is obligated by law to provide advance notice of separation ("Notice

Period"), then any Severance Pay hereunder shall be reduced by the amount of any

such severance pay, termination indemnity, notice pay or the like, as

applicable, and by the amount of any compensation received during any Notice

Period.

                  21.3  Neither the establishment of the Plan, nor any

modification thereof, nor the creation of any fund, trust or account, nor the

payment of any benefits shall be construed as giving any Eligible Employee, or

any person whomsoever, the right to be retained in the service of the Company,

and all Eligible Employees shall remain subject to discharge to the same extent

as if the Plan had never been adopted.

                  21.4  If any provision of this Plan shall be held invalid or

unenforceable, such invalidity or unenforceability shall not affect any other

provisions hereof, and this Plan shall be construed and enforced as if such

provisions had not been included.

                  21.5  This Plan shall inure to the benefit of and be binding

upon the heirs, executors, administrators, successors and assigns of the

parties, including each Eligible Employee, present and future, and any successor

to the Company. If a Severed Employee shall die while any amount would still be

payable to such Severed Employee hereunder if the Severed Employee had continued

to live, all such amounts, unless otherwise provided herein, shall be paid in

accordance with the terms of this Plan to the executor, personal representative

or administrators of the Severed Employee's estate.

                  21.6  The headings and captions herein are provided for

reference and convenience only, shall not be considered part of the Plan, and

shall not be employed in the construction of the Plan.

<PAGE>

                  21.7  The Plan shall not be funded. No Eligible Employee shall

have any right to, or interest in, any assets of the Company which may be

applied by the Company to the payment of benefits or other rights under this

Plan.

                  21.8  Any notice or other communication required or permitted

pursuant to the terms hereof shall have been duly given when delivered or mailed

by United States Mail, first class, postage prepaid, addressed to the intended

recipient at his, her or its last known address.

                  21.9  This Plan shall be construed and enforced according to

the laws of the State of New York to the extent not preempted by federal law,

which shall otherwise control.

<PAGE>

                                                                      SCHEDULE A

                     WAIVER AND RELEASE OF CLAIMS AGREEMENT
                     --------------------------------------

                  YOU HAVE BEEN ADVISED TO CONSULT AN ATTORNEY PRIOR TO SIGNING
THIS AGREEMENT.

                  YOU HAVE [FORTY-FIVE (45)] [TWENTY-ONE (21)] DAYS AFTER
RECEIVING THIS AGREEMENT TO CONSIDER WHETHER TO SIGN IT.

                  AFTER SIGNING THIS AGREEMENT, YOU HAVE ANOTHER SEVEN (7) DAYS
IN WHICH TO REVOKE IT, AND IT DOES NOT TAKE EFFECT UNTIL THOSE SEVEN (7) DAYS
HAVE ENDED.

                  In consideration of, and subject to, the payments to be made
to me by Immunex Corporation ("Immunex") or any of its subsidiaries, pursuant to
the Immunex Corporation Amended and Restated Leadership Continuity Policy (the
"Plan"), which I acknowledge that I would not otherwise be entitled to receive,
I hereby waive any claims I may have for employment or re-employment by Immunex
or any subsidiary or parent of Immunex after the date hereof, and I further
agree to and do release and forever discharge Immunex or any subsidiary or
parent of Immunex and their respective past and present officers, directors,
shareholders, employees and agents from any and all claims and causes of action,
known or unknown, arising out of or relating to my employment with Immunex or
any subsidiary or parent of Immunex or the termination thereof, including, but
not limited to, wrongful discharge, breach of contract, tort, fraud, the Civil
Rights Acts, Age Discrimination in Employment Act, Employee Retirement Income
Security Act, Americans with Disabilities Act, or any other federal, state or
local legislation or common law relating to employment or discrimination in
employment or otherwise.

                  Notwithstanding the foregoing or any other provision hereof,
nothing in this Waiver and Release of Claims Agreement shall adversely affect
(i) my rights under the Plan; (ii) my rights to benefits other than severance
benefits under plans, programs and arrangements of Immunex or any subsidiary or
parent of Immunex; or (iii) my rights to indemnification under any
indemnification agreement, applicable law and the certificates of incorporation
and bylaws of Immunex and any subsidiary or parent of Immunex, and my rights
under any director's and officer's liability insurance policy covering me.

                  I acknowledge that I have signed this Waiver and Release of
Claims Agreement voluntarily, knowingly, of my own free will and without
reservation or duress, and that no promises or representations, written or oral,
have been made to me by any person to induce me to do so other than the promise
of payment set forth in the first paragraph above and Immunex's acknowledgment
of my rights reserved under the second paragraph above.

                  I understand that this release will be deemed to be an
application for benefits under the Plan, and that my entitlement thereto shall
be governed by the terms and conditions of the Plan, and I expressly hereby
consent to such terms and conditions.

                  I acknowledge that I have been given not less than [forty-five
(45)] [twenty-one (21)] days to review and consider this Waiver and Release of
Claims Agreement, and that I have had the opportunity to consult with an
attorney or other advisor of my choice and have been advised by Immunex to do so
if I choose. I may revoke this Waiver and Release of Claims Agreement seven (7)
days or less after its execution by providing written notice to Immunex.

                  Finally, I acknowledge that I have carefully read this Waiver
and Release of Claims Agreement and understand all of its terms. This is the
entire Agreement between the parties and is legally binding and enforceable.

<PAGE>

                  This Waiver and Release of Claims Agreement shall be governed
and interpreted under federal law and the laws of New York.

                  I knowingly and voluntarily sign this Waiver and Release of
Claims Agreement.

Date Delivered to Employee:                          Immunex Corporation

___________________________

Date Signed by Employee:                    By:  _______________________

________________________                    Title:  ______________________

Seven-Day Revocation Period Ends:

____________________________

Signed:  _________________                  Date:  ______________________

____________________________
    (Print Employee's Name)<PAGE>
                                                                    EXHIBIT 10.9

                       IDMEDICAL.COM, INC. 2002 STOCK PLAN

SECTION 1. INTRODUCTION

         1.1 Establishment. Effective as provided in Section 17, IDMedical.com,
Inc., a Colorado corporation (the "Company"), hereby establishes this plan of
stock-based compensation incentives for selected Eligible Participants of the
Company and its affiliated corporations. This Plan shall be known as the
IDMedical.com, Inc. Stock Plan (the "Plan").

         1.2 Purpose. The purpose of this Plan is to promote the best interest
of the Company, and its stockholders by providing a means of non-cash
remuneration to selected Eligible Participants.

SECTION 2. DEFINITIONS

         The following definitions shall be applicable to the terms used in this
Plan:

         2.1 "Affiliated Corporation" means any corporation that is either a
parent corporation with respect to the Company or a subsidiary corporation with
respect to the Company (within the meaning of Sections 424(e) and (f),
respectively, of the Internal Revenue Code).

         2.2 "Code" means the Internal Revenue Code of 1986, as it may be
amended from time to time.

         2.3 "Committee" means a committee designated by the Board of Directors
to administer this Plan or, if no committee is so designated, the Board of
Directors. Any Committee member who is also an Eligible Participant may receive
an Option or Stock Award only if he abstains from voting in favor of a grant to
himself, and the grant is determined and approved by the remaining Committee
members. The Board of Directors, in its sole discretion, may at any time remove
any member of the Committee and appoint another Director to fill any vacancy on
the Committee.

         2.4 "Common Stock" means the Company's $0.001 par value common stock.

         2.5 "Company" means IDMedical.com, Inc., a Colorado corporation and its
subsidiaries.

         2.6 "Effective Date" means the effective date of this Plan, as set
forth in Section 17 hereof.

         2.7 "Eligible Participant" means any employee, director, officer,
consultant, or advisor of the Company who is determined (in accordance with the
provisions of Section 4 hereof) to be eligible to receive an Option or Stock
Award hereunder.

         2.8 "Option" means the grant to an Eligible Participant of a right to
acquire shares of Common Stock.

         2.9 "Plan" means this IDMedical.com, Inc. 2002 Stock Plan dated March
8, 2002

         2.10 "Stock Award" means the grant to an Eligible Participant of shares
of Common Stock issuable directly under this Plan rather than upon exercise of
an Option.

         Wherever appropriate, words used in this Plan in the singular may mean
the plural, the plural may mean the singular, and the masculine may mean the
feminine.

--------------------------------------------------------------------------------
IDMEDICAL.COM, INC. 2002 STOCK PLAN                                  PAGE 1 OF 6
<PAGE>

SECTION 3. ADOPTION AND ADMINISTRATION OF THIS PLAN

         Upon adoption by the Company's Board of Directors, this Plan became
effective as of March 8, 2002. In the absence of contrary action by the Board of
Directors, and except for action taken by the Committee pursuant to Section 4 in
connection with the determination of Eligible Participants, any action taken by
the Committee or by the Board of Directors with respect to the implementation,
interpretation or administration of this Plan shall be final, conclusive and
binding.

SECTION 4. ELIGIBILITY AND AWARDS

         The Committee shall determine at any time and from time to time after
the effective date of this Plan: (i) the Eligible Participants; (ii) the number
of shares of Common Stock issuable directly or to be granted pursuant to an
Option; (iii) the price per share at which each Option may be exercised, in cash
or cancellation of fees for services for which the Company is liable, if
applicable, or the value per share if a direct issue of stock pursuant to a
Stock Award; and (iv) the terms on which each Option may be granted. Such
determination, as may from time to time be amended or altered at the sole
discretion of the Committee. Notwithstanding the provisions of Section 3 hereof,
no such determination by the Committee shall be final, conclusive and binding
upon the Company unless and until the Board of Directors has approved the same;
provided, however, that if the Committee is composed of a majority of the
persons then comprising the Board of Directors of the Company, such approval by
the Board of Directors shall not be necessary.

SECTION 5. GRANT OF OPTION OR STOCK AWARD

         Subject to the terms and provisions of this Plan, the terms and
conditions under which an Option or Stock Award may be granted to an Eligible
Participant shall be set forth in a written agreement (i.e., a Consulting
Agreement, Services Agreement, Fee Agreement, or Employment Agreement) or, if an
Option, a written Grant of Option in the form attached hereto as Exhibit A
(which may contain such modifications thereto and such other provisions as the
Committee, in its sole discretion, may determine).

SECTION 6. TOTAL NUMBER OF SHARES OF COMMON STOCK

         The total number of shares of Common Stock reserved for issuance by the
Company either directly as Stock Awards or underlying Options granted under this
Plan shall not be more than 15,000,000. The total number of shares of Common
Stock reserved for such issuance may be increased only by a resolution adopted
by the Board of Directors and amendment of this Plan. Such Common Stock may be
authorized and unissued or reacquired Common Stock of the Company.

SECTION 7. PURCHASE OF SHARES OF COMMON STOCK

         7.1 As soon as practicable after the determination by the Committee and
approval by the Board of Directors (if necessary, pursuant to Section 4 hereof)
of the Eligible Participants and the number of shares an Eligible Participant
may be issued directly as a Stock Award or eligible to purchase pursuant to an
Option, the Committee shall give written notice thereof to each Eligible
Participant, which notice may be accompanied by the Grant of Option, if
appropriate, to be executed by such Eligible Participant.

         7.2 The negotiated cost basis of stock issued directly as a Stock Award
or the exercise price for each Option to purchase shares of Common Stock
pursuant to paragraph 7.1 shall be as determined by the Committee, it being
understood that the price so determined by the Committee may vary from one
Eligible Participant to another. In computing the negotiated direct issue price
as a Stock Award or the Option exercise price per share of Common Stock, the
Committee shall take into consideration, among other factors, the restrictions
set forth in Section 11 hereof.

--------------------------------------------------------------------------------
IDMEDICAL.COM, INC. 2002 STOCK PLAN                                  PAGE 2 OF 6
<PAGE>

SECTION 8. TERMS AND CONDITIONS OF OPTIONS

         The Committee shall determine the terms and conditions of each Option
granted to Eligible Participants, which terms shall be set forth in writing. The
terms and conditions so set by the Committee may vary from one Eligible
Participant to another. In the event that all the Committee approves an Option
permitting deferred payments, the Eligible Participant's obligation to pay for
such Common Stock may be evidenced by a promissory note executed by such
Eligible Participant and containing such modifications thereto and such other
provisions as the Committee, in its sole discretion, may determine.

SECTION 9. DELIVERY OF SHARES OF COMMON STOCK UPON EXERCISE OF OPTION

         The Company shall deliver to each Eligible Participant such number of
shares of Common Stock as such Eligible Participant is entitled to receive
pursuant to a Stock Award or elects to purchase upon exercise of the Option.
Such shares, which shall be fully paid and nonassessable upon the issuance
thereof (unless a portion or all of the purchase price shall be paid on a
deferred basis) shall be represented by a certificate or certificates registered
in the name of the Eligible Participant and stamped with an appropriate legend
referring to the restrictions thereon, if any. Subject to the terms and
provisions of the Colorado Business Corporation Act and the written agreement to
which he is a party, an Eligible Participant shall have all the rights of a
stockholder with respect to such shares, including the right to vote the shares
and to receive all dividends or other distributions paid or made with respect
thereto (except to the extent such Eligible Participant defaults under a
promissory note, if any, evidencing the deferred purchase price for such
shares), provided that such shares shall be subject to the restrictions
hereinafter set forth. In the event of a merger or consolidation to which the
Company is a party, or of any other acquisition of a majority of the issued and
outstanding shares of Common Stock of the Company involving an exchange or a
substitution of stock of an acquiring corporation for Common Stock of the
Company, or of any transfer of all or substantially all of the assets of the
Company in exchange for stock of an acquiring corporation, a determination as to
whether the stock of the acquiring corporation so received shall be subject to
the restrictions set forth in Section 11 shall be made solely by the acquiring
corporation.

SECTION 10. RIGHTS OF EMPLOYEES; ELIGIBLE PARTICIPANTS

         10.1 Employment. Nothing contained in this Plan or in any Option or
Stock Award granted under this Plan shall confer upon any Eligible Participant
any right with respect to the continuation of his or her employment by the
Company or any Affiliated Corporation, or interfere in any way with the right of
the Company or any Affiliated Corporation, subject to the terms of any separate
employment agreement to the contrary, at any time to terminate such employment
or to increase or decrease the compensation of the Eligible Participant from the
rate in existence at the time of the grant of an Option or Stock Award. Whether
an authorized leave of absence, or absence in military or government service,
shall constitute termination of employment shall be determined by the Committee
at the time.

         10.2 Non-transferability. No right or interest of any Eligible
Participant in an Option or Stock Award shall be assignable or transferable
during the lifetime of the Eligible Participant, either voluntarily or
involuntarily, or subjected to any lien, directly or indirectly, by operation of
law, or otherwise, including execution, levy, garnishment, attachment, pledge or
bankruptcy. However, the Board of Directors may, in its sole discretion, permit
transfers to family members if and to the extent such transfers are permissible
under applicable securities laws. In the event of an Eligible Participant's
death, an Eligible Participant's rights and interest in an Option or Stock Award
shall be transferable by testamentary will or the laws of descent and
distribution, and delivery of any shares of Common Stock due under this Plan
shall be made to, and exercise of any Options may be made by, the Eligible
Participant's legal representatives, heirs or legatees. If in the opinion of the
Committee a person entitled to payments or to exercise rights with respect to
this Plan is unable to care for his or her affairs because of mental condition,
physical condition, or age, payment due such person may be made to, and such
rights shall be exercised by, such person's guardian, conservator or other legal
personal representative upon furnishing the Committee with evidence satisfactory
to the Committee of such status.

--------------------------------------------------------------------------------
IDMEDICAL.COM, INC. 2002 STOCK PLAN                                  PAGE 3 OF 6
<PAGE>

SECTION 11. GENERAL RESTRICTIONS

         11.1 Representations. The Company may require any Eligible Participant
to whom an Option or Stock Award is granted, as a condition of exercising such
Option, or receiving such Stock Award, to give written assurances in substance
and form satisfactory to the Company and its counsel to the effect that such
person is acquiring the Common Stock subject to the Option or Stock Award for
his or her own account for investment and not with any present intention of
selling or otherwise distributing the same, and to such other effects as the
Company deems necessary or appropriate in order to comply with federal and
applicable state securities laws.

         11.2 Restrictions on Transfer of Common Stock. The shares of Common
Stock issuable directly as a Stock Award or upon exercise of an Option may not
be offered for sale, sold or otherwise transferred except pursuant to an
effective registration statement or pursuant to an exemption from registration,
the availability of which is to be established to the satisfaction of the
Company, and any certificates representing shares of Common Stock will bear a
legend to that effect. However, the Company may, in the sole discretion of the
Board of Directors, register with the Securities and Exchange Commission some or
all of the shares of Common Stock reserved for issuance under this Plan. Special
resale restrictions may, however, continue to apply to officers, directors,
control shareholders and affiliates of the Company and such persons will be
required to obtain an opinion of counsel as regards their ability to resell
shares received pursuant to this Plan.

         11.3 Compliance with Securities Laws. Each Option or Stock Award shall
be subject to the requirement that if at any time counsel to the Company shall
determine that the listing, registration or qualification of the shares of
Common Stock subject to such Option or Stock Award upon any securities exchange
or under any state or federal law, or the consent or approval of any
governmental or regulatory body, is necessary as a condition of, or in
connection with, the issuance or purchase of shares thereunder, such Option or
Stock Award may not be accepted or exercised in whole or in part unless such
listing, registration, qualification, consent or approval shall have been
effected or obtained on conditions acceptable to the Committee. Nothing herein
shall be deemed to require the Company to apply for or to obtain such listing,
registration or qualification.

         11.4 Changes in Accounting Rules. Notwithstanding any other provision
of this Plan to the contrary, if, during the term of this Plan, any changes in
the financial or tax accounting rules applicable to Options or Stock Awards
shall occur that, in the sole judgment of the Committee, may have a material
adverse effect on the reported earnings, assets or liabilities of the Company,
the Committee shall have the right and power to modify as necessary, or cancel,
any then outstanding and unexercised Options.

SECTION 12. COMPLIANCE WITH TAX REQUIREMENTS

         Each Eligible Participant shall be liable for payment of all applicable
federal, state and local income taxes incurred as a result of the receipt of a
Stock Award or an Option, the exercise of an Option, and the sale of any shares
of Common Stock received pursuant to a Stock Award or upon exercise of an
Option. The Company may be required, pursuant to applicable tax regulations, to
withhold taxes for an Eligible Participant, in which case the Company's
obligations to deliver shares of Common Stock upon the exercise of any Option
granted under this Plan or pursuant to any Stock Award, shall be subject to the
Eligible Participant's satisfaction of all applicable federal, state and local
income and other income tax withholding requirements.

SECTION 13. PLAN BINDING UPON ASSIGNS OR TRANSFEREES

         In the event that, at any time or from time to time, any Option or
Stock Award is assigned or transferred to any party (other than the Company)
pursuant to the provisions of Section 10.2 hereof, such party shall take such
Option or Stock Award pursuant to all provisions and conditions of this Plan,
and, as a condition precedent to the transfer of such interest, such party shall
agree (for and on behalf of himself or itself, his or its legal representatives
and his or its transferees and assigns) in writing to be bound by all provisions
of this Plan.

--------------------------------------------------------------------------------
IDMEDICAL.COM, INC. 2002 STOCK PLAN                                  PAGE 4 OF 6
<PAGE>

SECTION 14. COSTS AND EXPENSES

         All costs and expenses with respect to the adoption, implementation,
interpretation and administration of this Plan shall be borne by the Company.

SECTION 15. CHANGES IN CAPITAL STRUCTURE OF THE COMPANY

         Appropriate adjustments shall be made to the number of shares of Common
Stock issuable pursuant to an incomplete or pending Stock Award that has not yet
been delivered or upon exercise of any Options and the exercise price thereof in
the event of: (i) a subdivision or combination of any of the shares of capital
stock of the Company; (ii) a dividend payable in shares of capital stock of the
Company; (iii) a reclassification of any shares of capital stock of the Company;
or (iv) any other change in the capital structure of the Company.

SECTION 16. PLAN AMENDMENT, MODIFICATION AND TERMINATION

         The Board, upon recommendation of the Committee or at its own
initiative, at any time may terminate and at any time and from time to time and
in any respect, may amend or modify this Plan, including:

                  (a) Increase the total amount of Common Stock that may be
         awarded under this Plan, except as provided in Section 15 of this Plan;

                  (b) Change the classes of persons from which Eligible
         Participants may be selected or materially modify the requirements as
         to eligibility for participation in this Plan;

                  (c) Increase the benefits accruing to Eligible Participants;
         or

                  (d) Extend the duration of this Plan.

         Any Option or other Stock Award granted to a Eligible Participant prior
to the date this Plan is amended, modified or terminated will remain in effect
according to its terms unless otherwise agreed upon by the Eligible Participant;
provided, however, that this sentence shall not impair the right of the
Committee to take whatever action it deems appropriate under Section 11 or
Section 15. The termination or any modification or amendment of this Plan shall
not, without the consent of a Eligible Participant, affect his rights under an
Option or other Stock Award previously granted to him.

SECTION 17. EFFECTIVE DATE OF THIS PLAN

         17.1 Effective Date. This Plan is effective as of March 8, 2002, the
date it was adopted by the Board of Directors of the Company.

         17.2 Duration of this Plan. This Plan shall terminate at midnight on
March 8, 2007, which is the day before the fifth anniversary of the Effective
Date, and may be extended thereafter or terminated prior thereto by action of
the Board of Directors; and no Option or Stock Award shall be granted after such
termination. Options and Stock Awards outstanding at the time of this Plan
termination may continue to be exercised, or become free of restrictions, in
accordance with their terms.

--------------------------------------------------------------------------------
IDMEDICAL.COM, INC. 2002 STOCK PLAN                                  PAGE 5 OF 6
<PAGE>

SECTION 18. BURDEN AND BENEFIT

         The terms and provisions of this Plan shall be binding upon, and shall
inure to the benefit of, each Eligible Participant, his executives or
administrators, heirs, and personal and legal representatives.

         Dated as of the 8th day of March 2002.

                                   IDMEDICAL.COM, INC.

                                   By: /s/ Robert P. Gordon
                                       -----------------------------------------
                                       Robert P. Gordon, Chief Executive Officer

--------------------------------------------------------------------------------
IDMEDICAL.COM, INC. 2002 STOCK PLAN                                  PAGE 6 OF 6
<PAGE>

                                    EXHIBIT A

                                     FORM OF
                         GRANT OF OPTION PURSUANT TO THE
                            IDMEDICAL 2002 STOCK PLAN

         IDMedical.com, Inc., a Colorado corporation (the "Company"), hereby
grants to ________________________________ ("Optionee") an Option to purchase
___________ shares of common stock, $0.001 par value (the "Shares") of the
Company at the purchase price of $______ per share (the "Purchase Price"), in
accordance with and subject to the terms and conditions of the IDMedical.com,
Inc. 2002 Stock Plan (the "Plan"). This option is exercisable in whole or in
part, and upon payment in cash or cancellation of fees, or other form of payment
acceptable to the Company, to the principal office of the Company. This Grant of
Option supersedes and replaces any prior notice of option grant, description of
vesting terms or similar documents previously delivered to Optionee for options
granted on the date stated below.

         Unless otherwise set forth in a separate written agreement, in the
event that Optionee's employee or consultant status with the Company or any of
its subsidiaries ceases or terminates for any reason whatsoever, including, but
not limited to, death, disability, or voluntary or involuntary cessation or
termination, this Grant of Option shall terminate with respect to any portion of
this Grant of Option that has not vested prior to the date of cessation or
termination of employee or consultant status, as determined in the sole
discretion of the Company. In the event of termination for cause, this Grant of
Option shall immediately terminate in full with respect to any un-exercised
options, and any vested but un-exercised options shall immediately expire and
may not be exercised. Unless otherwise set forth in a separate written
agreement, vested options must be exercised within six months after the date of
termination (other than for cause), notwithstanding the Expiration Date set
forth below.

         Subject to the preceding paragraph, this Grant of Option, or any
portion hereof, may be exercised only to the extent vested per the attached
schedule, and must be exercised by Optionee no later than
____________________________ (the "Expiration Date") by (i) notice in writing,
signed by Optionee; and (ii) payment of the Purchase Price of a minimum of
$1,000 (unless the Purchase Price for the exercise of all vested options
available to be exercised totals less than $1,000) pursuant to the terms of this
Grant of Option and the Plan. Any portion of this Grant of Option that is not
exercised on or before the Expiration Date shall lapse. The notice must refer to
this Grant of Option, and it must specify the number of shares being purchased,
and recite the consideration being paid therefor. Notice shall be deemed given
on the date on which the notice is received by the Company.

         This Option shall be considered validly exercised once payment therefor
has cleared the banking system or the Company has issued a credit memo for
services in the appropriate amount, or receives a duly executed acceptable
promissory note, if the Option is granted with deferred payment, and the Company
has received written notice of such exercise. If payment is not received within
two business days after the date the notice is received, the Company may deem
the notice to be invalid.

         If Optionee fails to exercise this Option in accordance with this Grant
of Option, then this Grant of Option shall terminate and have no force and
effect, in which event the Company and Optionee shall have no liability to each
other with respect to this Grant of Option.

         This Option may be executed simultaneously in two or more counterparts,
each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument.

         The validity, construction and enforceability of this Grant of Option
shall be construed under and governed by the laws of the State of Colorado,
without regard to its rules concerning conflicts of laws, and any action brought
to enforce this Grant of Option or resolve any controversy, breach or

--------------------------------------------------------------------------------
IDMEDICAL.COM, INC. 2002 STOCK PLAN                                     PAGE A-1
<PAGE>

disagreement relative hereto shall be brought only in a court of competent
jurisdiction within the state and county of the Company's principal office.

         The shares of common stock issuable upon exercise of the Option (the
"Underlying Shares") may not be sold, exchanged, assigned, transferred or
permitted to be transferred, whether voluntarily, involuntarily or by operation
of law, delivered, encumbered, discounted, pledged, hypothecated or otherwise
disposed of until (i) the Underlying Shares have been registered with the
Securities and Exchange Commission pursuant to an effective registration
statement on Form S-8, or such other form as may be appropriate, in the
discretion of the Company; or (ii) an Opinion of Counsel, satisfactory to the
Company, has been received, which opinion sets forth the basis and availability
of any exemption for resale or transfer from federal or state securities
registration requirements.

         This Grant of Option relates to options granted on _________________,
_____.

                                        IDMEDICAL.COM, INC.

                                        BY THE BOARD OF DIRECTORS
                                        OR A SPECIAL COMMITTEE THEREOF

                                            NOT FOR EXECUTION
                                        By:
                                           -------------------------------------

OPTIONEE:

NOT FOR EXECUTION

------------------------------------

--------------------------------------------------------------------------------
IDMEDICAL.COM, INC. 2002 STOCK PLAN                                     PAGE A-2
<PAGE>

GRANT OF OPTION PURSUANT TO THE
IDMEDICAL.COM, INC. 2002 STOCK PLAN

<Table>
<S>                     <C>             <C>
OPTIONEE:               ___________________
OPTIONS GRANTED:        ___________________
PURCHASE PRICE:         $______per Share
DATE OF GRANT:          ___________________
EXERCISE PERIOD:        ________ to _______

VESTING SCHEDULE:       OPTION ON
                        #SHARES             DATE VESTED (ASSUMING CONTINUED EMPLOYMENT, ETC.)

                        ----------      ------------

                        ----------      ------------

                        ----------      ------------

                        ----------      ------------

                        ----------      ------------

EXERCISED TO DATE:         _________  INCLUDING THIS EXERCISE
BALANCE TO BE EXERCISED:   _________
</Table>

================================================================================

                               NOTICE OF EXERCISE
                 (TO BE SIGNED ONLY UPON EXERCISE OF THE OPTION)

TO:      IDMedical.com, Inc. ("Optionor")

         The undersigned, the holder of the Option described above, hereby
irrevocably elects to exercise the purchase rights represented by such Option
for, and to purchase thereunder, _________________ shares of the Common Stock of
IDMedical.com, Inc., and herewith makes payment of ____________________________
therefor. Optionee requests that the certificates for such shares be issued in
the name of Optionee and be delivered to Optionee at the address of
____________________________________________________________________, and if
such shares shall not be all of the shares purchasable hereunder, represents
that a new Notice of Exercise of like tenor for the appropriate balance of the
shares, or a portion thereof, purchasable under the Grant of Option pursuant to
the IDMedical.com, Inc. 2002 Stock Plan, be delivered to Optionor when and as
appropriate.

                                        OPTIONEE:

                                        NOT FOR EXECUTION
Dated:
      ---------------------------       ----------------------------------------

--------------------------------------------------------------------------------
IDMEDICAL.COM, INC. 2002 STOCK PLAN                                     PAGE A-3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00034-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00034-of-00352.parquet"}]]